The prognostic value of cognition in patients with glioblastoma multiforme

被引：0
|
作者：
Flechl, Birgit
Sax, Cornelia
Ackerl, Michael
Crevenna, Richard
Gaiger, Alexander
Dieckmann, Karin
Widhalm, Georg
Marosi, Christine
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Med Univ Hosp, Vienna, Austria
[3] Med Univ Vienna, Dept Radiat Therapy & Radiat Biol, Vienna, Austria
[4] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[5] Med Univ Vienna, Div Clin Oncol, Dept Med 1, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2078
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic factors in patients with glioblastoma multiforme (clinical research)
    Ekici, Mehmet Ali
    Bulut, Turgay
    Tucer, Bulent
    Basarslan, Seyit Kaan
    Kurtsoy, Ali
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2013, 43 (05) : 795 - 804
  • [22] The prognostic significance of volumetry in patients with glioblastoma multiforme (GBM)
    Iliadis, G.
    Selviaridis, P.
    Kalogera-Fountzila, A.
    Fragkoulidi, A.
    Baltas, D.
    Misailidou, D.
    Zamboglou, N.
    Fountzilas, G.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 498 - 498
  • [23] PROGNOSTIC FACTORS AND OUTCOMES FOR ELDERLY PATIENTS WITH GLIOBLASTOMA MULTIFORME
    Laperriere, N.
    Menard, C.
    Millar, B. A.
    Sahgal, A.
    Payne, D.
    Mason, W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S34 - S34
  • [24] Survival and prognostic factors of patients with unresectable glioblastoma multiforme
    Fazeny-Dörner, B
    Wenzel, C
    Veitl, M
    Piribauer, M
    Rössler, K
    Dieckmann, K
    Ungersböck, K
    Marosi, C
    [J]. ANTI-CANCER DRUGS, 2003, 14 (04) : 305 - 312
  • [25] Prognostic value of pre-operative neutrophil-to-lymphocyte ratio in patients with glioblastoma multiforme
    Kemal, Y.
    Oltulu, O.
    Odabasi, E.
    Ozdemir, O.
    Yucel, I.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [26] Prognostic value of relative cerebral blood volume in patients with recurrent glioblastoma multiforme treated with bevacizumab
    Stecco, Alessandro
    Amatuzzo, Paola
    Sponghini, Andrea P.
    Platini, Francesca
    Quagliozzi, Martina
    Buemi, Francesco
    Guenzi, Elena
    Carriero, Alessandro
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2019, 63 (04) : 394 - 401
  • [27] Prognostic factors in glioblastoma multiforme
    Hulshof, MCCM
    Koot, RW
    Schimmel, EC
    Dekker, F
    Bosch, DA
    González, DG
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (06) : 283 - 290
  • [28] Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival
    Rahbar, Afsar
    Orrego, Abiel
    Peredo, Inti
    Dzabic, Mensur
    Wolmer-Solberg, Nina
    Straat, Klas
    Stragliotto, Giuseppe
    Soderberg-Naucler, Cecilia
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (01) : 36 - 42
  • [29] PROGNOSTIC AND PREDICTIVE VALUE OF MGMT EVALUATED BY IMMUNOHISTOCHEMISTRY IN A SERIES OF GLIOBLASTOMA MULTIFORME
    Moller, Soren
    Broholm, Helle
    Poulsen, Hans Skovgaard
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 648 - 648
  • [30] Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
    Yang, Ji'an
    Wang, Long
    Xu, Zhou
    Wu, Liquan
    Liu, Baohui
    Wang, Junmin
    Tian, Daofeng
    Xiong, Xiaoxing
    Chen, Qianxue
    [J]. FRONTIERS IN GENETICS, 2020, 11
12345